Stay updated on Seladelpar in PBC with Compensated Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page.

Latest updates to the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the study page.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedAdded numerous recruiting sites worldwide, bringing the total locations to 178, with new sites in the UK, Taiwan, Singapore, Israel, Hong Kong, France, Czechia, China, Belgium, Argentina, and the United States. The total site count changed from 159 to 178.SummaryDifference1%

- Check47 days agoChange DetectedThe page shows a new revision entry: v3.4.2, replacing the previous v3.4.1 in the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedThe list of participating study sites was updated, adding many new locations across the U.S., Europe, Asia, and other regions, while a few existing sites were removed.SummaryDifference2%

- Check61 days agoChange DetectedThe page now displays additional metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted), No FEAR Act Data, and a Revision: v3.4.0, replacing Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Seladelpar in PBC with Compensated Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page.